Literature DB >> 31096089

DrugR+: A comprehensive relational database for drug repurposing, combination therapy, and replacement therapy.

Yosef Masoudi-Sobhanzadeh1, Yadollah Omidi2, Massoud Amanlou3, Ali Masoudi-Nejad4.   

Abstract

Drug repurposing or repositioning, which introduces new applications of the existing drugs, is an emerging field in drug discovery scope. To enhance the success rate of the research and development (R&D) process in a cost- and time-effective manner, a number of pharmaceutical companies worldwide have made tremendous investments. Besides, many researchers have proposed various methods and databases for the repurposing of various drugs. However, there is not a proper and well-organized database available. To this end, for the first time, we developed a new database based on DrugBank and KEGG data, which is named "DrugR+". Our developed database provides some advantages relative to the DrugBank, and its interface supplies new capabilities for both single and synthetic repositioning of drugs. Moreover, it includes four new datasets which can be used for predicting drug-target interactions using supervised machine learning methods. As a case study, we introduced novel applications of some drugs and discussed the obtained results. A comparison of several machine learning methods on the generated datasets has also been reported in the Supplementary File. Having included several normalized tables, DrugR + has been organized to provide key information on data structures for the repurposing and combining applications of drugs. It provides the SQL query capability for professional users and an appropriate method with different options for unprofessional users. Additionally, DrugR + consists of repurposing service that accepts a drug and proposes a list of potential drugs for some usages. Taken all, DrugR+ is a free web-based database and accessible using (http://www.drugr.ir), which can be updated through a map-reduce parallel processing method to provide the most relevant information.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Keywords:  Database: combination therapy; Drug repositioning; Drug repurposing; DrugR+

Year:  2019        PMID: 31096089     DOI: 10.1016/j.compbiomed.2019.05.006

Source DB:  PubMed          Journal:  Comput Biol Med        ISSN: 0010-4825            Impact factor:   4.589


  11 in total

1.  Impact of 5HydroxyMethylCytosine (5hmC) on reverse/direct association of cell-cycle, apoptosis, and extracellular matrix pathways in gastrointestinal cancers.

Authors:  Sayyed Sajjad Moravveji; Samane Khoshbakht; Majid Mokhtari; Mahdieh Salimi; Hossein Lanjanian; Sajjad Nematzadeh; Mahsa Torkamanian-Afshar; Ali Masoudi-Nejad
Journal:  BMC Genom Data       Date:  2022-06-29

2.  Drug repositioning in non-small cell lung cancer (NSCLC) using gene co-expression and drug-gene interaction networks analysis.

Authors:  Habib MotieGhader; Parinaz Tabrizi-Nezhadi; Mahshid Deldar Abad Paskeh; Behzad Baradaran; Ahad Mokhtarzadeh; Mehrdad Hashemi; Hossein Lanjanian; Seyed Mehdi Jazayeri; Masoud Maleki; Ehsan Khodadadi; Sajjad Nematzadeh; Farzad Kiani; Mazaher Maghsoudloo; Ali Masoudi-Nejad
Journal:  Sci Rep       Date:  2022-06-08       Impact factor: 4.996

3.  Structure-based drug repurposing against COVID-19 and emerging infectious diseases: methods, resources and discoveries.

Authors:  Yosef Masoudi-Sobhanzadeh; Aysan Salemi; Mohammad M Pourseif; Behzad Jafari; Yadollah Omidi; Ali Masoudi-Nejad
Journal:  Brief Bioinform       Date:  2021-11-05       Impact factor: 11.622

4.  Machine learning methods, databases and tools for drug combination prediction.

Authors:  Lianlian Wu; Yuqi Wen; Dongjin Leng; Qinglong Zhang; Chong Dai; Zhongming Wang; Ziqi Liu; Bowei Yan; Yixin Zhang; Jing Wang; Song He; Xiaochen Bo
Journal:  Brief Bioinform       Date:  2022-01-17       Impact factor: 11.622

5.  Recent trends in artificial intelligence-driven identification and development of anti-neurodegenerative therapeutic agents.

Authors:  Kushagra Kashyap; Mohammad Imran Siddiqi
Journal:  Mol Divers       Date:  2021-07-19       Impact factor: 3.364

6.  Trader as a new optimization algorithm predicts drug-target interactions efficiently.

Authors:  Yosef Masoudi-Sobhanzadeh; Yadollah Omidi; Massoud Amanlou; Ali Masoudi-Nejad
Journal:  Sci Rep       Date:  2019-06-27       Impact factor: 4.379

7.  A machine learning method based on the genetic and world competitive contests algorithms for selecting genes or features in biological applications.

Authors:  Yosef Masoudi-Sobhanzadeh; Habib Motieghader; Yadollah Omidi; Ali Masoudi-Nejad
Journal:  Sci Rep       Date:  2021-02-08       Impact factor: 4.379

Review 8.  Strategies to identify candidate repurposable drugs: COVID-19 treatment as a case example.

Authors:  Ali S Imami; Robert E McCullumsmith; Sinead M O'Donovan
Journal:  Transl Psychiatry       Date:  2021-11-16       Impact factor: 6.222

9.  A fuzzy logic-based computational method for the repurposing of drugs against COVID-19.

Authors:  Yosef Masoudi-Sobhanzadeh; Hosein Esmaeili; Ali Masoudi-Nejad
Journal:  Bioimpacts       Date:  2021-08-10

Review 10.  Transformative dynamism in pharmaceutical and biomedical research: Complexity of integration of innovative R & D hubs.

Authors:  Yadollah Omidi; Hossein Omidian
Journal:  Bioimpacts       Date:  2021-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.